The immune suppressive microenvironment observed in our cohort of NSCLC included not only the PD-L1/PD-1 axis but also other inhibitory pathways, such as the LAG3, VISTA, and TIM3 pathways, and myeloid-derived suppressor cells. The gene discussed is HAVCR2; the disease is non-small cell lung carcinoma.